Wednesday, November 29, 2023 7:27:15 PM
Again, this issue you keep repeating is absurd and misleading. The company hasn't disclosed that information not for any hidden negative reasons as you are implying. They haven't done it because it doesn't make any sense to compare:232 randomized patients to:
1. The 99 original placebo arm, because 64 of them received DCVax
2. The 35 (99-64) non crossover patients, because they lost all of the randomization. What was randomized was the whole 99 original placebo arm and the ones that remained in the non-crossover group were the ones that didn't crossover. These 35 patients are not the result of any randomization.
In any case you would be comparing apples to oranges.
Having said that, I have to say that I agree with what flipper have been saying:
I think that in the case they found those LTFU, that would benefit the arms comparison in DCVax's favor for the previous OS endpoint because of the following reasons:
1. The effect of not having censors and instead having the actual information for sicker patients would affect negatively an arm in the trial as flipper explained in some of his posts and I expained in the post I'm linking below.
2. All of the censors in the 2018 JTM interim results publication for the first 16 months from randomization (19 months from surgery) were left censors (LTFUs) and also all of them were part of the original control arm (99 patients arm). None of them were part of the treatment arm (232 patients arm). And these are the reasons:
- In JAMA article with final results there were no censors for the first two years from randomization for the treatment arm (232 patients arm), while in the 2018 JTM interim results publication there were 13 censors for the first 19 months from surgery (16 from randomization) that were necessarily LTFU because of the time from enrollment of the last patient.
- Those LTFU patients were not just taken out of the treatment arm because it continued having 232 patients as before.
All of these details are explained in post 479394 in the following link:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168995681
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM